October 1, 2009 - While we wait for the definition of "meaningful use," Dr. David Blumenthal, M.D., M.P.P., National Coordinator for Health Information Technology, recommends physicians become "as familiar as possible with the discussion of meaningful use criteria to date."

October 1, 2009 – Transcatheter heart valve company CardiAQ Valve Technologies (CVT), which is developing the world’s first self-conforming and self-anchoring technology for transcatheter mitral valve implantation (TMVI) system, announced successful results at TCT 2009 from its acute in vivo study.

October 1, 2009 – Invatec recently launched the REEF HP PTA Balloon Catheter at CIRSE 2009, which the company said is ideal for use in all peripheral high-pressure dilatation procedures.

September 30, 2009 – PLC Systems Inc. demonstrated its RenalGuard System to help prevent contrast-induced nephropathy (CIN) and presented data from its MYTHOS Clinical Trial at the Transcatheter Cardiovascular Therapeutics (TCT) 2009 symposium last week in San Francisco.

September 30, 2009 – New clinical data released at TCT 2009 last week showed strong and sustained efficacy and safety of the Resolute Zotarolimus-Eluting Coronary Stent from Medtronic Inc. in long-term patient follow-up.

September 30, 2009 – A simple, noninvasive test appears to be an effective screening tool for identifying patients with silent heart disease who are at risk for a heart attack or sudden death.

September 30, 2009 – MAQUET Cardiovascular said Johannes Bonatti, M.D., professor of surgery and director of coronary surgery and advanced coronary interventions at the University of Maryland Heart Center in Baltimore, recently completed the world's first use of the MAQUET Minimized Extra-Corporeal Circulation (MECC) system during a successful robotic and fully endoscopic heart surgery.